LECT2 and metabolic dysfunction-associated steatotic liver disease: Therefore, LECT2 is also closely associated with a variety of liver diseases, such as non-alcoholic fatty liver disease (NAFLD) (Yoo et al., 2017), and liver fibrogenesis (Xu et al., 2019), and hepatocellular carcinoma (Chen et al., 2016).